My cart
In the shopping cart is not goods, to choose and buy!
  • Product Name
  • Size
  • Quantity
  • Amount
    Selected items : 0 pieces Total : CHECK OUT()
    Catalog No: V0074
    CAS No. (CAS Registry Number): 871361-88-5
    Description: SC66 is a novel, potent and allosteric inhibitor of AKT which reduces cell viability in a dose- and time-dependent manner, inhibits colony formation and induces apoptosis in hep...
    Catalog No: V0123
    CAS No. (CAS Registry Number): 1013101-36-4
    Description: PF-04691502 is a novel, potent, ATP-competitive and dual inhibitor of PI3K (phosphatidylinositol 3 kinase) and mTOR (mammalian target of rapamycin) with Ki of 1.8 nM/2.1 nM/1.6 nM/1.9 nM ...
    Catalog No: V0155
    CAS No. (CAS Registry Number): 1032350-13-2
    Description: MK-2206 dihydrochloride (2HCl) is a novel, potent, orally bioavailable and highly selective allosteric inhibitor of the serine/threonine protein kinase Akt1/2/3 with IC50 of 8 nM/12 nM/65...
    Catalog No: V0156
    CAS No. (CAS Registry Number): 157716-52-4
    Description: Perifosine (also known as KRX-0401) is a potent, orally bioavailable and synthetic antitumor alkylphospholipid which acts as an Akt inhibitor and a PI3K inhibitor. It induces ce...
    Catalog No: V0157
    CAS No. (CAS Registry Number): 937174-76-0
    Description: GSK690693 is a novel, potent and ATP-competitive pan-Akt inhibitor targeting Akt1/2/3 with IC50 of 2 nM/13 nM/9 nM in cell-free assays, it is also sensitive to the AGC kinase fa...
    Catalog No: V0158
    CAS No. (CAS Registry Number): 1001264-89-6
    Description: Ipatasertib (formerly also called GDC-0068) is a novel, potent, orally bioavailable, ATP-competitive and highly selective pan-Akt inhibitor targeting Akt1/2/3 with IC50 of 5 nM/18 nM/8 nM...
    Products are for research use only;  We do not sell to patients
    Tel: 1-708-310-1919
    Fax: 1-708-557-7486
    Subscribe to our E-newsletter
    • Name*
    • *
    • E-mail*
    • *
    • instructions:
    • *
    Copyright 2020 InvivoChem LLC | All Rights Reserved